BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27470218)

  • 21. Bone marrow transplantation from matched related donors for patients with Fanconi anemia using low-dose busulfan and cyclophosphamide as conditioning.
    Torjemane L; Ladeb S; Ben Othman T; Abdelkefi A; Lakhal A; Ben Abdeladhim A
    Pediatr Blood Cancer; 2006 Apr; 46(4):496-500. PubMed ID: 16333862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternative donor hematopoietic cell transplantation for Fanconi anemia.
    MacMillan ML; DeFor TE; Young JA; Dusenbery KE; Blazar BR; Slungaard A; Zierhut H; Weisdorf DJ; Wagner JE
    Blood; 2015 Jun; 125(24):3798-804. PubMed ID: 25824692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Better posttransplant outcome with fludarabine based conditioning in multitransfused fanconi anemia patients who underwent peripheral blood stem cell transplantation.
    Yesilipek MA; Karasu GT; Kupesiz A; Uygun V; Hazar V
    J Pediatr Hematol Oncol; 2009 Jul; 31(7):512-5. PubMed ID: 19564748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-haploidentical T-cell receptor αβT/B-cell-depleted stem cell transplantation for Fanconi anemia.
    Iguchi A; Uchiyama T; Fujimori K; Gocho Y; Sakaguchi H; Deguchi T; Tomizawa D; Imadome KI; Onodera M; Matsumoto K
    Int J Hematol; 2024 Mar; 119(3):334-337. PubMed ID: 38227075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogeneic hematopoietic stem cell transplantation from an alternative stem cell source in Fanconi anemia patients: analysis of 47 patients from a single institution.
    de Medeiros CR; Bitencourt MA; Zanis-Neto J; Maluf EC; Carvalho DS; Bonfim CS; Funke VM; Setubal DC; Farah N; Pasquini R
    Braz J Med Biol Res; 2006 Oct; 39(10):1297-304. PubMed ID: 17053839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hematopoietic Stem Cell Transplant in Adolescent and Young Adults With Fanconi Anemia Is Feasible With Acceptable Toxicity, With Those Surviving 100 Days Posttransplant Having Excellent Outcomes.
    Alhuraiji A; Alzahrani H; Al Mohareb F; Chaudhri N; Alsharif F; Mohamed S; Rasheed W; Aldawsari G; Ahmed SO; Aljurf M
    Exp Clin Transplant; 2016 Dec; 14(6):660-664. PubMed ID: 27447289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allogeneic stem cell transplantation in patients with Fanconi's anemia and myelodysplasia or leukemia utilizing low-dose cyclophosphamide and total body irradiation.
    Ayas M; Al-Jefri A; Al-Mahr M; Rifai S; Moussa E; Karaoui M; Roberts G; El-Solh H
    Bone Marrow Transplant; 2004 Jan; 33(1):15-7. PubMed ID: 14578932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study.
    Kang HJ; Shin HY; Park JE; Chung NG; Cho B; Kim HK; Kim SY; Lee YH; Lim YT; Yoo KH; Sung KW; Koo HH; Im HJ; Seo JJ; Park SK; Ahn HS;
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1582-8. PubMed ID: 20685256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1/2 study.
    Straathof KC; Rao K; Eyrich M; Hale G; Bird P; Berrie E; Brown L; Adams S; Schlegel PG; Goulden N; Gaspar HB; Gennery AR; Landais P; Davies EG; Brenner MK; Veys PA; Amrolia PJ
    Lancet; 2009 Sep; 374(9693):912-20. PubMed ID: 19729196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stem cell transplantation from HLA-matched related donor for Fanconi's anaemia: a retrospective review of the multicentric Italian experience on behalf of AIEOP-GITMO.
    Dufour C; Rondelli R; Locatelli F; Miano M; Di Girolamo G; Bacigalupo A; Messina C; Porta F; Balduzzi A; Iorio AP; Buket E; Madon E; Pession A; Dini G; Di Bartolomeo P; ;
    Br J Haematol; 2001 Mar; 112(3):796-805. PubMed ID: 11260086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Cape Town experience with haematopoietic stem cell transplantation: the paediatric programme.
    Roux P; Novitzky N
    S Afr Med J; 2000 Aug; 90(8):804-11. PubMed ID: 11022631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA.
    Lawler M; McCann SR; Marsh JC; Ljungman P; Hows J; Vandenberghe E; O'Riordan J; Locasciulli A; Socié G; Kelly A; Schrezenmeier H; Marin P; Tichelli A; Passweg JR; Dickenson A; Ryan J; Bacigalupo A;
    Br J Haematol; 2009 Mar; 144(6):933-45. PubMed ID: 19183198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matched sibling donor stem cell transplantation for Fanconi anemia patients with T-cell somatic mosaicism.
    Yabe M; Shimizu T; Morimoto T; Koike T; Takakura H; Tsukamoto H; Muroi K; Oshima K; Asami K; Takata M; Yamashita T; Kato S; Yabe H
    Pediatr Transplant; 2012 Jun; 16(4):340-5. PubMed ID: 22404423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matched-related allogeneic stem cell transplantation in Saudi patients with Fanconi anemia: 10 year's experience.
    Ayas M; Al-Jefri A; Al-Seraihi A; Elkum N; Al-Mahr M; El-Solh H
    Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S45-S48. PubMed ID: 18724300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Late effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors.
    Anur P; Friedman DN; Sklar C; Oeffinger K; Castiel M; Kearney J; Singh B; Prockop SE; Kernan NA; Scaradavou A; Kobos R; Curran K; Ruggiero J; Zakak N; O'Reilly RJ; Boulad F
    Bone Marrow Transplant; 2016 Jul; 51(7):938-44. PubMed ID: 26999465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does anti-thymocyte globulin have a place in busulfan/fludarabine conditioning for matched related donor hematopoietic stem cell transplantation?
    Ji YS; Lee MS; Min CW; Park SK; Kim SH; Yun J; Kim HJ; Kim KH; Kim CK; Lee KT; Won JH; Hong DS
    Korean J Intern Med; 2016 Jul; 31(4):750-61. PubMed ID: 27017944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful HSCT using nonradiotherapy-based conditioning regimens and alternative donors in patients with Fanconi anaemia--experience in a single UK centre.
    Motwani J; Lawson SE; Darbyshire PJ
    Bone Marrow Transplant; 2005 Sep; 36(5):405-10. PubMed ID: 15995715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of Fanconi anemia patients using fludarabine and low-dose TBI, followed by unrelated donor hematopoietic cell transplantation.
    Thakar MS; Kurre P; Storb R; Kletzel M; Frangoul H; Pulsipher MA; Leisenring W; Flowers ME; Sandmaier BM; Woolfrey A; Kiem HP
    Bone Marrow Transplant; 2011 Apr; 46(4):539-44. PubMed ID: 20581880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of allogeneic haematopoietic stem cell transplantation in aplastic anaemia.
    Ahmed P; Chaudhry QU; Raza S; Mahmood SK; Satti TM; Anwar M; Altaf C; Shahbaz N; Satti HS
    J Coll Physicians Surg Pak; 2012 Sep; 22(9):553-9. PubMed ID: 22980607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study.
    Güngör T; Teira P; Slatter M; Stussi G; Stepensky P; Moshous D; Vermont C; Ahmad I; Shaw PJ; Telles da Cunha JM; Schlegel PG; Hough R; Fasth A; Kentouche K; Gruhn B; Fernandes JF; Lachance S; Bredius R; Resnick IB; Belohradsky BH; Gennery A; Fischer A; Gaspar HB; Schanz U; Seger R; Rentsch K; Veys P; Haddad E; Albert MH; Hassan M;
    Lancet; 2014 Feb; 383(9915):436-48. PubMed ID: 24161820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.